Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenoid Cystic Carcinoma of the Lacrimal Gland With Late Mandibular Metastasis Presenting as an Intraoral Mass: A Case Report and Literature Review.

Cureus·2026
Same author

Exploring the relationship between microplastic exposure and bone health.

Endocrine connections·2026
Same author

Perspectives of Healthcare Professionals on the Treatment Landscape of Ocular Redness.

Patient preference and adherence·2026
Same author

Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye Symptoms: A Randomized, Investigator-Masked Study.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025
Same author

Parainflammation in the Ocular System: Considerations on the Underlying Mechanisms and Treatment of Dry Eye Disease.

Ophthalmology and therapy·2025
Same author

Current and emerging bone resorption inhibitors for the treatment of osteoporosis.

Expert opinion on pharmacotherapy·2025

Related Experiment Video

Updated: Jun 13, 2026

Grossing of Non-neoplastic Globes, Including Fetal Eyes
05:15

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Published on: May 30, 2025

Pediatric aspects in Graves' orbitopathy.

Apostolos I Gogakos1, Kostas Boboridis, Gerasimos E Krassas

  • 1Molecular Endocrinology Group, MRC, Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, UK.

Pediatric Endocrinology Reviews : PER
|May 15, 2010
PubMed
Summary
This summary is machine-generated.

Pediatric Graves' ophthalmopathy (GO) presents milder than in adults, with common symptoms like lid lag. Management focuses on hyperthyroidism control and watchful waiting for eye changes.

More Related Videos

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Related Experiment Videos

Last Updated: Jun 13, 2026

Grossing of Non-neoplastic Globes, Including Fetal Eyes
05:15

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Published on: May 30, 2025

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Pediatrics

Background:

  • Pediatric Graves' disease is uncommon, but children face similar risks of Graves' ophthalmopathy (GO) as adults.
  • GO in children typically presents with milder symptoms like lid lag, soft tissue involvement, and proptosis, unlike the more severe manifestations seen in adults.

Purpose of the Study:

  • To explore the characteristics and management of Graves' ophthalmopathy in children and adolescents.
  • To compare pediatric GO presentation and outcomes with adult GO.
  • To discuss potential contributing factors and treatment strategies for juvenile GO.

Main Methods:

  • Review of existing literature on pediatric Graves' disease and Graves' ophthalmopathy.
  • Analysis of clinical presentations, risk factors, and treatment outcomes in pediatric populations.
  • Comparison of juvenile GO with adult GO based on reported data.

Main Results:

  • Children exhibit milder GO symptoms, with rare occurrences of severe strabismus or optic neuropathy.
  • Smoking is a significant risk factor for GO severity, with increasing prevalence in adolescents.
  • Antithyroid drugs are the primary treatment for hyperthyroidism, with limited long-term remission rates.
  • A 'wait-and-see' approach is common for eye changes, with steroids used for deterioration in euthyroid patients.

Conclusions:

  • Juvenile GO is generally milder than adult GO, with distinct clinical features.
  • Effective hyperthyroidism management is crucial for controlling GO complications.
  • While adult treatments like retrobulbar irradiation are not recommended for children, newer somatostatin analogs show promise.